Dr. Lucas has had a relationship with Bio-Techne since its inception, serving as vice president of research, chief scientific officer, and founder of the Biotechnology Division. He holds a Ph.D. in physiology and cell biology from the Illinois Institute of Technology.
Distinguished Professor of Medicine and Immunology at the University of Colorado Medical Center at Denver, Dr. Dinarello is a member of the National Academy of Sciences and one of the founders of the cytokine field of research.
Professor and past Chairman of the Department of Developmental Biology at Stanford University, Dr. Nusse is a member of both the Institute for Stem Cell Biology and Regenerative Medicine and the National Academy of Sciences. He is also an investigator with the Howard Hughes Medical Institute.
Dr. Artis recently was appointed the founding Director of the Roberts Institute for Research in IBD at Weill Cornell Medical College. Prior to that, Dr. Artis was Associate Professor in Microbiology at the University of Pennsylvania Perelman School of Medicine, and Program Director of Inflammation for the Penn Institute of Immunology. Dr. Artis' research focuses on the body's immune system, how it fights infection and how its normal function can become dysregulated, leading to the development of chronic inflammatory diseases including psoriasis, arthritis and inflammatory bowel disease.
In addition to his faculty position with the Biomolecular Chemistry department at the University of Wisconsin - Madison, Dr. Denu was also appointed several years ago as the Epigenetics Theme Leader at the Wisconsin Institutes of Discovery, which explores key areas of scientific inquiry with a cross-disciplinary focus. Dr. Denu's current focus is understanding the molecular mechanisms of epigenetic regulators, and their impact on physiology (particularly on stem cell biology and metabolism.
In addition to his position as Professor with the Donnelly Centre for Cellular and Biomolecular Research, Dr. Sidhu is also a Senior Investigator at the Ontario Institute for Cancer Research, Department of Protein Engineering, at the University of Toronto. Building on his antibody expertise honed earlier as a scientist at Genentech in California, Dr. Sidhu also established the cutting-edge Toronto Recombinant Antibody Centre (TRAC) at the University of Toronto. Dr. Sidhu's research is primarily focused in the field of protein engineering and technologies that explore and shape protein and antibody structure and function, with the aim of crafting better therapies for cancer, diabetes and other diseases.